Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Is US drug manufacturing homeward bound?

New US President Donald Trump has indicated that he wants to reform drug manufacturing for the US market, emphasising domestic production rather than outsourcing to plants abroad. Abi Millar looks into the US’s current pharma manufacturing and drug supply chain, asking what it would take to shift the production base back inside US borders.

Go Top